Partnership for Safe Medicines Applauds Reintroduction of the Cooper Davis Devin Norring Act
Washington, D.C. — [July 22, 2025] — The Partnership for Safe Medicines (PSM) today announced its strong support for the reintroduction of the Cooper Davis Devin Norring Act, a bipartisan effort aimed at curbing the online sale of deadly counterfeit and illicit drugs. (HR 4518 / S. XXX)
“The reintroduction of the Cooper Davis Devin Norring Act marks a critical step forward in the fight against the fentanyl crisis,” said Shabbir Imber Safdar, Executive Director of the Partnership for Safe Medicines. “By requiring social media and tech platforms to report suspected drug trafficking to the DEA, this legislation empowers law enforcement to act swiftly and decisively. It’s a commonsense measure that will save lives and protect families from the devastating impact of counterfeit drugs.”
Named in honor of Cooper Davis, a Kansas teenager who tragically lost his life to a counterfeit pill laced with fentanyl, and Devin Norring, a young adult from Minnesota who tragically lost his life from fentanyl poisoning during the pandemic, the Act underscores the urgent need for accountability and transparency in the digital space.
PSM urges Congress to act quickly to pass this life-saving legislation.
Key data
Rep. Miller Meeks Press Release
Rep. Craig Press Release
Rep. Schrier Press Release
House Co-Sponsors: Rep. Schrier (D-WA), Rep. Crenshaw (R-TX), Rep. Davis (D-NC), Rep. McDowell (R-NC), Rep. Suozzi (D-NY), Rep. Schmidt (R-KS), Rep. Van Drew (R-NJ)
Senate Bill Number TBD
Senate Bill Text (identical to House version)
Sen. Shaheen Press Release
Sen. Marshall Press Release
Sen. Young Press Release
Senate Judiciary Committee Press Release
Senate Co-Sponsors: Sen. Grassley (R-IA), Sen. Durbin (D-IL), Sen. Young (R-IN), Sen. Klobuchar (D-MN)
About the Partnership for Safe Medicines
The Partnership for Safe Medicines is a public health group committed to ensuring the safety of prescription drugs and protecting consumers from counterfeit, substandard or otherwise unsafe medicines. Comprised of more than 40 non-profit organizations, PSM studies counterfeit drug crime, threats to American patients, and educates the public, policymakers, and health care professionals about threats to the safety of the U.S. drug supply.